Elvis Rosado, education and community outreach coordinator of Prevention Point in Philadelphia, said that the recall would not negatively impact the needle exchange program because they do not use the recalled product. Instead, Prevention Point uses a nasal spray by Adapt Pharma, Inc., known as Narcan, which does not require the use of a syringe.